ketofin and metformin Alone
Phase 2Small molecule
ketofin and metformin Alone is one of 9 small molecule programs targeting Metformin. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
11 competitors in Metformin
#DrugCompanyPhaseTrials
1Glucophage
EMD SeronoApproved
Glucophage
EMD SeronoApproved
Galvus
NovartisPhase 3
Myoinositol
SSohag University
Phase 3
HDM1005 1
HHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
Metformin Pill
FFudan University
Phase 2
ketofin and metformin Alone
AAssiut University
Phase 2
Henagliflozin
TThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Preclinical
Metformin /ml
RRanbaxy Laboratories Limited
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Metformin1 trial
Topical Metformin Versus Topical Ketotifen in Melasma Treatment
Not yet recruiting·—·Phase 2·NCT06942390·60 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for ketofin and metformin Alone. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- AAssiut University